rs143885622

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000377.3(WAS):​c.1378C>T​(p.Pro460Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,207,556 control chromosomes in the GnomAD database, including 19 homozygotes. There are 812 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P460R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., 57 hem., cov: 23)
Exomes 𝑓: 0.0020 ( 19 hom. 755 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 1.13

Publications

9 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002421677).
BP6
Variant X-48689359-C-T is Benign according to our data. Variant chrX-48689359-C-T is described in ClinVar as Benign. ClinVar VariationId is 135411.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00177 (197/111431) while in subpopulation EAS AF = 0.0307 (108/3513). AF 95% confidence interval is 0.026. There are 0 homozygotes in GnomAd4. There are 57 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 197 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASNM_000377.3 linkc.1378C>T p.Pro460Ser missense_variant Exon 11 of 12 ENST00000376701.5 NP_000368.1 P42768A0A024QYX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASENST00000376701.5 linkc.1378C>T p.Pro460Ser missense_variant Exon 11 of 12 1 NM_000377.3 ENSP00000365891.4 P42768

Frequencies

GnomAD3 genomes
AF:
0.00179
AC:
199
AN:
111378
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000981
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000855
Gnomad ASJ
AF:
0.00189
Gnomad EAS
AF:
0.0312
Gnomad SAS
AF:
0.00113
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00123
Gnomad OTH
AF:
0.00267
GnomAD2 exomes
AF:
0.00343
AC:
603
AN:
175583
AF XY:
0.00340
show subpopulations
Gnomad AFR exome
AF:
0.0000803
Gnomad AMR exome
AF:
0.000521
Gnomad ASJ exome
AF:
0.00329
Gnomad EAS exome
AF:
0.0334
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00111
Gnomad OTH exome
AF:
0.00161
GnomAD4 exome
AF:
0.00204
AC:
2241
AN:
1096125
Hom.:
19
Cov.:
31
AF XY:
0.00209
AC XY:
755
AN XY:
361727
show subpopulations
African (AFR)
AF:
0.000114
AC:
3
AN:
26387
American (AMR)
AF:
0.000428
AC:
15
AN:
35043
Ashkenazi Jewish (ASJ)
AF:
0.00280
AC:
54
AN:
19320
East Asian (EAS)
AF:
0.0291
AC:
878
AN:
30159
South Asian (SAS)
AF:
0.00112
AC:
60
AN:
53474
European-Finnish (FIN)
AF:
0.000149
AC:
6
AN:
40325
Middle Eastern (MID)
AF:
0.000727
AC:
3
AN:
4126
European-Non Finnish (NFE)
AF:
0.00134
AC:
1128
AN:
841292
Other (OTH)
AF:
0.00204
AC:
94
AN:
45999
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
94
188
282
376
470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00177
AC:
197
AN:
111431
Hom.:
0
Cov.:
23
AF XY:
0.00170
AC XY:
57
AN XY:
33621
show subpopulations
African (AFR)
AF:
0.0000979
AC:
3
AN:
30643
American (AMR)
AF:
0.000854
AC:
9
AN:
10544
Ashkenazi Jewish (ASJ)
AF:
0.00189
AC:
5
AN:
2647
East Asian (EAS)
AF:
0.0307
AC:
108
AN:
3513
South Asian (SAS)
AF:
0.00113
AC:
3
AN:
2647
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5999
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00123
AC:
65
AN:
53017
Other (OTH)
AF:
0.00264
AC:
4
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00253
Hom.:
23
Bravo
AF:
0.00216
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000692
AC:
2
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00193
AC:
13
ExAC
AF:
0.00321
AC:
389

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3Other:1
Aug 01, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

not provided Benign:3
Dec 05, 2014
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28535968, 25931402, 29358862, 30738478, 20232122, 24728327, 21185603, 22692965, 32463623, 27330000, 19775295, 25091438) -

Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Wiskott-Aldrich syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Benign
0.29
T
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
0.98
L
PhyloP100
1.1
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.18
Sift
Benign
0.074
T
Sift4G
Benign
0.27
T
Polyphen
0.041
B
Vest4
0.064
MVP
0.69
MPC
0.59
ClinPred
0.0051
T
GERP RS
1.1
Varity_R
0.053
gMVP
0.36
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143885622; hg19: chrX-48547748; API